Medical Marijuana Inc (OTCMKTS:MJNA) reported that August 2017 was the firm’s largest revenue month in its all-time history. In addition, wholly-owned subsidiaries HempMeds® and Kannaway® Mexico witnessed their largest months of revenue in their individual histories.
Blake Schroeder, the CEO of Kannaway, reported that the company’s growth has been especially remarkable since it was launched again in March 2016. Kannaway’s revenue has jumped more than 25 times during that period, and the firm plans to release a series of new offerings in Q4 2017 as it prepares for its regional treaty this fall in Denver, Co. In addition, there are plans to release into Europe in this year. The company anticipate Kannaway’s aggressive growth to advance in the coming period.
Dr. Stuart Titus, the CEO of Medical Marijuana, reported that as they continue to grow into new territories, they are delighted to watch the firm record milestone after milestone. The portfolio of firms continues to create thrilling developments in the CBD sector. Medical Marijuana and its portfolio of firms are going as planned for a banner year, in respect of gross sales revenue figures.
Titus added that this jump in revenue is enabling them to further their research and development measures, which is important to their long-term shareholder valuation plans. Over the last months, they have added some remarkable new additions to Kannaway’s portfolio and they look forward to advancing this leadership within the industry.
Due to the innovative measures taken now and then, Medical Marijuana is known as a company of firsts. Its main goal is to become the major hemp and cannabis industry innovators, using its expert team to source, assess and acquire value-added companies as well as products, while able to keep their entrepreneurial and integrity spirit. The company take all the